ponasterone A
Modify Date: 2024-01-13 17:30:45
ponasterone A structure
|
Common Name | ponasterone A | ||
|---|---|---|---|---|
| CAS Number | 13408-56-5 | Molecular Weight | 464.635 | |
| Density | 1.2±0.1 g/cm3 | Boiling Point | 640.5±55.0 °C at 760 mmHg | |
| Molecular Formula | C27H44O6 | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | 355.2±28.0 °C | |
Use of ponasterone APonasterone A (25-Deoxyecdysterone), an ecdysteroid, has strong affinity for the ecdysone receptor. Ponasterone A is a potent regulator of gene expression in cells and transgenic animals, enabling reporter genes to be turned on and off rapidly[1][2]. |
| Name | ponasterone A |
|---|---|
| Synonym | More Synonyms |
| Description | Ponasterone A (25-Deoxyecdysterone), an ecdysteroid, has strong affinity for the ecdysone receptor. Ponasterone A is a potent regulator of gene expression in cells and transgenic animals, enabling reporter genes to be turned on and off rapidly[1][2]. |
|---|---|
| Related Catalog | |
| Target |
ecdysone receptor[2] |
| In Vitro | Ponasterone A (1 nM-100 μM) shows significant gene induction activity in CV-1 cells[2]. |
| In Vivo | Ponasterone A (3-10 mg; i.p.) produces robust inductions of gene expression in transactivator and reporter mice[2]. |
| References |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 640.5±55.0 °C at 760 mmHg |
| Molecular Formula | C27H44O6 |
| Molecular Weight | 464.635 |
| Flash Point | 355.2±28.0 °C |
| Exact Mass | 464.313782 |
| PSA | 118.22000 |
| LogP | 1.55 |
| Vapour Pressure | 0.0±4.3 mmHg at 25°C |
| Index of Refraction | 1.582 |
| Storage condition | −20°C |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| Hazard Codes | Xi |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
|
Endogenous CCL2 neutralization restricts HIV-1 replication in primary human macrophages by inhibiting viral DNA accumulation.
Retrovirology 12 , 4, (2015) Macrophages are key targets of HIV-1 infection. We have previously described that the expression of CC chemokine ligand 2 (CCL2) increases during monocyte differentiation to macrophages and it is furt... |
|
|
A single-residue change in the HIV-1 V3 loop associated with maraviroc resistance impairs CCR5 binding affinity while increasing replicative capacity.
Retrovirology 12 , 50, (2015) Maraviroc (MVC) is an allosteric CCR5 inhibitor used against HIV-1 infection. While MVC-resistant viruses have been identified in patients, it still remains incompletely known how they adjust their CD... |
|
|
Genome-wide promoter binding profiling of protein phosphatase-1 and its major nuclear targeting subunits.
Nucleic Acids Res. 43 , 5771-84, (2015) Protein phosphatase-1 (PP1) is a key regulator of transcription and is targeted to promoter regions via associated proteins. However, the chromatin binding sites of PP1 have never been studied in a sy... |
| 25-Deoxyecdysterone |
| (2b,3b,5b,22R)-2,3,14,20,22-Pentahydroxycholest-7-en-6-one |
| ponasterone A |
| (2β,3β,5β,22R)-2,3,14,20,22-Pentahydroxycholest-7-en-6-one |
| Cholest-7-en-6-one, 2,3,14,20,22-pentahydroxy-, (2β,3β,5β,22R)- |
| 25-Deoxy-20-hydroxyecdysone |
| MFCD00272144 |
| (2S,3R,5R,9R,10R,13R,14S,17S)-17-[(2R,3R)-2,3-dihydroxy-6-methylheptan-2-yl]-2,3,14-trihydroxy-10,13-dimethyl-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one |